Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Cancer treatments often cause skin, nail, and hair problems.

WYE-130600 may cause skin thickening and irritation.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

DFMO may help control hair growth and treat cancer.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Blocking JAK-STAT signaling can lead to hair growth.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Erlotinib can cause hair loss as a side effect.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.